The Influence of Arginine and Counter-Ions: Antibody Stability during Freeze-Drying.

Antibody Arginine Freeze-drying Lyophilization Protein aggregation Sucrose

Journal

Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R

Informations de publication

Date de publication:
05 2021
Historique:
received: 21 06 2020
revised: 01 12 2020
accepted: 07 12 2020
pubmed: 15 12 2020
medline: 22 6 2021
entrez: 14 12 2020
Statut: ppublish

Résumé

Amino acids, for example L-arginine, are used in lyophilisation as crystalline bulking, buffering, viscosity reducing or stabilising excipients. In this study, arginine was formulated with different counter ions (hydrochloride, citrate, lactobionate, phosphate, and succinate). A monoclonal antibody was investigated in sugar-free arginine formulations and mixtures with sucrose regarding cake appearance and protein aggregation and fragmentation. Arginine hydrochloride formulations collapsed during lyophilisation due to its low Tg' and partially crystallised during storage, but provided the best protein stability at low antibody concentration, followed by arginine succinate. Arginine citrate/phosphate/lactobionate formulations resulted in amorphous elegant cakes, but inferior protein stability. Addition of sucrose improved cake appearance and protein stability. Arginine phosphate with sucrose resulted in similar protein stability as the sucrose reference. Mixtures of sucrose with arginine hydrochloride/lactobionate/succinate provided better stability than sucrose alone. While 50 mg/mL antibody improved the cake appearance, only arginine lactobionate provided sufficient protein stability next to sucrose. Overall, sugar-free arginine hydrochloride and lactobionate lyophilisates stabilised the antibody comparably or better than sucrose depending on antibody concentration. The best protein stability was found for mixtures of arginine hydrochloride/lactobionate/succinate with sucrose.

Identifiants

pubmed: 33316241
pii: S0022-3549(20)30788-7
doi: 10.1016/j.xphs.2020.12.009
pii:
doi:

Substances chimiques

Excipients 0
Ions 0
Sucrose 57-50-1
Arginine 94ZLA3W45F

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2017-2027

Informations de copyright

Copyright © 2020 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Auteurs

Ivonne Seifert (I)

Department of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Ludwig-Maximilians-Universität München, Munich, Germany.

Alessandro Bregolin (A)

Dipartimento di Scienza Applicata e Tecnologia, Politecnico di Torino, Turin, Italy.

Davide Fissore (D)

Dipartimento di Scienza Applicata e Tecnologia, Politecnico di Torino, Turin, Italy.

Wolfgang Friess (W)

Department of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Ludwig-Maximilians-Universität München, Munich, Germany. Electronic address: wolfgang.friess@lrz.uni-muenchen.de.

Articles similaires

Nanoparticles Needles Polylactic Acid-Polyglycolic Acid Copolymer Polyethylene Glycols Curcumin
Phosphatidylcholine-Sterol O-Acyltransferase Flavonoids Humans Allosteric Regulation Molecular Dynamics Simulation
Flurbiprofen Tablets Administration, Oral Drug Compounding Solubility

Sweet enhancers of polymerase chain reaction.

Binghua Xie, Jia Chen, Zhounan Wang et al.
1.00
Polymerase Chain Reaction Betaine Trehalose Sucrose Taq Polymerase

Classifications MeSH